Scott Benjamin Lovitch, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histocompatibility Antigens Class II | 6 | 2006 | 1475 | 0.810 |
Why?
|
Antigen Presentation | 7 | 2007 | 1284 | 0.660 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2017 | 189 | 0.570 |
Why?
|
Pathology, Surgical | 1 | 2016 | 155 | 0.500 |
Why?
|
Peptide Fragments | 5 | 2006 | 5097 | 0.330 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2007 | 71 | 0.290 |
Why?
|
T-Lymphocyte Subsets | 3 | 2005 | 1838 | 0.280 |
Why?
|
Myeloproliferative Disorders | 2 | 2023 | 606 | 0.280 |
Why?
|
Muramidase | 5 | 2007 | 174 | 0.270 |
Why?
|
Peptides | 3 | 2007 | 4409 | 0.260 |
Why?
|
Lymphocyte Activation | 5 | 2019 | 5524 | 0.260 |
Why?
|
Models, Immunological | 3 | 2005 | 527 | 0.250 |
Why?
|
Germinal Center | 2 | 2019 | 377 | 0.250 |
Why?
|
Immunotherapy | 2 | 2018 | 4445 | 0.240 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2021 | 2988 | 0.240 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10180 | 0.240 |
Why?
|
HLA-D Antigens | 1 | 2003 | 134 | 0.230 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2021 | 835 | 0.220 |
Why?
|
Antigen-Presenting Cells | 2 | 2003 | 973 | 0.220 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2019 | 986 | 0.200 |
Why?
|
Dendritic Cells | 3 | 2023 | 2725 | 0.200 |
Why?
|
Autoantigens | 2 | 2019 | 892 | 0.200 |
Why?
|
Hybridomas | 4 | 2007 | 452 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2021 | 1378 | 0.190 |
Why?
|
Histiocytes | 1 | 2021 | 103 | 0.190 |
Why?
|
Chromosomes, Human, Y | 1 | 2021 | 148 | 0.180 |
Why?
|
Hematologic Neoplasms | 2 | 2023 | 1832 | 0.180 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 381 | 0.160 |
Why?
|
Tumor Escape | 1 | 2021 | 349 | 0.160 |
Why?
|
Mosaicism | 1 | 2021 | 441 | 0.160 |
Why?
|
Histiocytic Sarcoma | 1 | 2017 | 44 | 0.150 |
Why?
|
Immune Tolerance | 3 | 2021 | 2258 | 0.140 |
Why?
|
Bone Marrow | 2 | 2023 | 2948 | 0.140 |
Why?
|
B-Lymphocytes | 3 | 2021 | 4665 | 0.140 |
Why?
|
Scapula | 1 | 2017 | 164 | 0.130 |
Why?
|
Lethargy | 1 | 2015 | 39 | 0.130 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2015 | 15 | 0.130 |
Why?
|
Anemia, Macrocytic | 1 | 2015 | 55 | 0.130 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2015 | 57 | 0.130 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 1116 | 0.120 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2017 | 340 | 0.120 |
Why?
|
Carboxy-Lyases | 1 | 2013 | 90 | 0.110 |
Why?
|
HLA Antigens | 1 | 2018 | 1381 | 0.110 |
Why?
|
Carbon | 1 | 2016 | 687 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2018 | 3474 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5686 | 0.100 |
Why?
|
Protein Conformation | 4 | 2015 | 4011 | 0.100 |
Why?
|
Signal Transduction | 5 | 2021 | 23403 | 0.100 |
Why?
|
Reperfusion Injury | 1 | 2018 | 1026 | 0.100 |
Why?
|
Fibrosis | 1 | 2018 | 2029 | 0.100 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 372 | 0.100 |
Why?
|
Erythropoiesis | 1 | 2015 | 705 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1102 | 0.090 |
Why?
|
Sirtuins | 1 | 2013 | 323 | 0.090 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 21827 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1596 | 0.090 |
Why?
|
Point Mutation | 1 | 2015 | 1623 | 0.090 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9734 | 0.080 |
Why?
|
Mice | 12 | 2021 | 81183 | 0.080 |
Why?
|
Protein Binding | 4 | 2015 | 9386 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3523 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.080 |
Why?
|
Headache | 1 | 2015 | 1226 | 0.080 |
Why?
|
Animals | 17 | 2021 | 168757 | 0.080 |
Why?
|
Autoimmunity | 1 | 2015 | 1349 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 1 | 2017 | 1363 | 0.070 |
Why?
|
Neoplasms | 1 | 2016 | 21683 | 0.070 |
Why?
|
Leukemia | 1 | 2015 | 1511 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 996 | 0.070 |
Why?
|
Hemolysin Proteins | 1 | 2007 | 113 | 0.070 |
Why?
|
Fimbriae Proteins | 1 | 2007 | 134 | 0.070 |
Why?
|
Proteome | 1 | 2016 | 1799 | 0.070 |
Why?
|
Isomerism | 1 | 2005 | 201 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1972 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2015 | 2564 | 0.070 |
Why?
|
Liposomes | 2 | 2006 | 759 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2529 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1889 | 0.060 |
Why?
|
Cytoplasmic Vesicles | 1 | 2004 | 74 | 0.060 |
Why?
|
Listeriosis | 1 | 2005 | 149 | 0.060 |
Why?
|
Antigens | 2 | 2007 | 1466 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 2957 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 805 | 0.060 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 18111 | 0.050 |
Why?
|
Heat-Shock Proteins | 1 | 2007 | 822 | 0.050 |
Why?
|
Kidney | 1 | 2018 | 7186 | 0.050 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2007 | 571 | 0.050 |
Why?
|
Immunodominant Epitopes | 1 | 2003 | 267 | 0.050 |
Why?
|
Immunization | 1 | 2007 | 1256 | 0.050 |
Why?
|
Amino Acid Sequence | 4 | 2015 | 13815 | 0.050 |
Why?
|
B-Lymphocyte Subsets | 1 | 2003 | 246 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4253 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2021 | 126 | 0.050 |
Why?
|
Bacterial Toxins | 1 | 2007 | 931 | 0.050 |
Why?
|
Humans | 19 | 2023 | 744343 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2021 | 2513 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2018 | 14557 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1878 | 0.050 |
Why?
|
Cytogenetic Analysis | 1 | 2021 | 295 | 0.050 |
Why?
|
Melanoma | 1 | 2018 | 5510 | 0.040 |
Why?
|
Clonal Deletion | 1 | 2019 | 79 | 0.040 |
Why?
|
Multigene Family | 1 | 2003 | 1102 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 596 | 0.040 |
Why?
|
Antigens, Dermatophagoides | 1 | 2019 | 100 | 0.040 |
Why?
|
Pyroglyphidae | 1 | 2019 | 88 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2216 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 880 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4386 | 0.040 |
Why?
|
Lymphotoxin beta Receptor | 1 | 2018 | 24 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 2 | 2016 | 1836 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 2 | 2005 | 1990 | 0.040 |
Why?
|
Male | 10 | 2021 | 350118 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2019 | 389 | 0.040 |
Why?
|
Gender Identity | 1 | 2021 | 688 | 0.030 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2015 | 64 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 294 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6600 | 0.030 |
Why?
|
Apoptosis | 3 | 2021 | 9727 | 0.030 |
Why?
|
Piracetam | 1 | 2015 | 87 | 0.030 |
Why?
|
Pyridoxal Phosphate | 1 | 2015 | 127 | 0.030 |
Why?
|
Female | 8 | 2023 | 380194 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2019 | 598 | 0.030 |
Why?
|
Epitopes | 2 | 2016 | 2571 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 881 | 0.030 |
Why?
|
Genomics | 2 | 2021 | 5720 | 0.030 |
Why?
|
Genes, X-Linked | 1 | 2015 | 128 | 0.030 |
Why?
|
Nootropic Agents | 1 | 2015 | 160 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1677 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1813 | 0.030 |
Why?
|
Reticulocytes | 1 | 2015 | 290 | 0.030 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2019 | 1463 | 0.030 |
Why?
|
Mutation | 3 | 2023 | 29786 | 0.030 |
Why?
|
Cell Membrane | 1 | 2003 | 3748 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2023 | 77449 | 0.030 |
Why?
|
Glutamine | 1 | 2016 | 578 | 0.030 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2015 | 183 | 0.030 |
Why?
|
Iron Overload | 1 | 2015 | 242 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2015 | 224 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2019 | 1348 | 0.030 |
Why?
|
Neck | 1 | 2017 | 697 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1042 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13102 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2015 | 275 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 827 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2015 | 880 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2503 | 0.030 |
Why?
|
Middle Aged | 4 | 2021 | 213383 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2014 | 1827 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 783 | 0.030 |
Why?
|
Proteins | 1 | 2007 | 6103 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 729 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2938 | 0.020 |
Why?
|
Tamoxifen | 1 | 2015 | 981 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 351 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1085 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2005 | 3336 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2015 | 1200 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18029 | 0.020 |
Why?
|
Antibody Formation | 1 | 2014 | 1402 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 19229 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2421 | 0.020 |
Why?
|
Cell Line | 1 | 2003 | 15997 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5853 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3586 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1951 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2765 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2187 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2866 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2751 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4560 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 3002 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6386 | 0.020 |
Why?
|
Trans-Activators | 1 | 2017 | 2924 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1524 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2003 | 16689 | 0.020 |
Why?
|
Antigens, CD | 1 | 2017 | 4026 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2018 | 2958 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5882 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
Fatty Acids | 1 | 2013 | 1809 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2016 | 2899 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5456 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4554 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3703 | 0.020 |
Why?
|
Oxygen | 1 | 2016 | 4189 | 0.020 |
Why?
|
Pyrimidines | 1 | 2016 | 2942 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7722 | 0.010 |
Why?
|
Glucose | 1 | 2016 | 4397 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3647 | 0.010 |
Why?
|
Adult | 4 | 2021 | 214055 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11366 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3520 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3638 | 0.010 |
Why?
|
Hemorrhage | 1 | 2015 | 3461 | 0.010 |
Why?
|
Chickens | 1 | 2005 | 865 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.010 |
Why?
|
Lipids | 1 | 2013 | 3305 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9648 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18370 | 0.010 |
Why?
|
Protein Transport | 1 | 2004 | 1988 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11483 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10638 | 0.010 |
Why?
|
Autoantibodies | 1 | 2005 | 2035 | 0.010 |
Why?
|
Diet | 1 | 2013 | 7939 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85781 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12745 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35421 | 0.000 |
Why?
|